As the abundance of genetically modified (GM) foods continues to grow, so does the demand for monitoring and labeling them. The genes of GM plants used for food are tweaked to make them more healthful ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Food and Drug Administration (FDA) approval of its in vitro diagnostic (IVD) TruSight™ ...

Illumina, Inc. ILMN launched the TruSight Oncology (“TSO”) Comprehensive (EU)— a single test that evaluates multiple tumor genes and biomarkers to identify the specific molecular profile of a ...

Lockheed Martin's three F-35 Lightning II strike fighter variants have completed what the company called the most comprehensive flight test program in aviation history. On April 11 at US Naval Air ...

(RTTNews) - Illumina, Inc. (ILMN), Tuesday announced that the Centers for Medicare and Medicaid Services or CMS has granted reimbursement for the company's FDA-approved in vitro diagnostic TruSight ...

Delivers Layer 1-3 Ethernet testing on a single platform that supports data center interconnect speeds from 10GE to 800GE Validates network equipment interoperability ...

This year marks the 20th anniversary of the moratorium on nuclear testing by the United States and the Soviet Union. Following a combined total of 2,000 test explosions, only a handful has been ...